BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3067179)

  • 1. Oscillatory potentials, macular recovery time, and diabetic retinopathy through 3 years of intensified insulin treatment.
    Brinchmann-Hansen O; Dahl-Jørgensen K; Hanssen KF; Sandvik L
    Ophthalmology; 1988 Oct; 95(10):1358-66. PubMed ID: 3067179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macular recovery recorded by nyctometry in insulin-dependent diabetes mellitus.
    Frost-Larsen K
    Acta Ophthalmol Suppl (1985); 1991; (203):1-39. PubMed ID: 1667959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of short-term near-normal blood glucose control on oscillatory potential and macular recovery time in insulin-dependent diabetic patients with long-standing metabolic dysregulation.
    Frost-Larsen K; Christiansen JS; Lauritzen T; Parving HH
    Acta Ophthalmol (Copenh); 1989 Aug; 67(4):405-8. PubMed ID: 2801043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macular recovery during onset and development of diabetic retinopathy in childhood and adolescence.
    Frost-Larsen K; Lund-Anderson C; Starup K
    Acta Ophthalmol (Copenh); 1989 Aug; 67(4):401-4. PubMed ID: 2801042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oscillatory potentials of local macular ERG in diabetic retinopathy.
    Yoon IH; Shiroyama N; Miyake Y; Awaya S
    Korean J Ophthalmol; 1990 Jun; 4(1):40-5. PubMed ID: 2214251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy.
    Brinchmann-Hansen O; Dahl-Jørgensen K; Hanssen KF; Sandvik L
    Arch Ophthalmol; 1988 Sep; 106(9):1242-6. PubMed ID: 3046587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macular recovery time, diabetic retinopathy, and clinical variables after 7 years of improved glycemic control.
    Brinchmann-Hansen O; Dahl-Jørgensen K; Hanssen KF; Sandvik L
    Acta Ophthalmol (Copenh); 1992 Apr; 70(2):235-42. PubMed ID: 1609574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 6 months of strict metabolic control on eye and kidney function in insulin-dependent diabetics with background retinopathy. Steno study group.
    Lancet; 1982 Jan; 1(8264):121-4. PubMed ID: 6119509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macular recovery function (nyctometry) in diabetics without and with early retinopathy.
    Midena E; Segato T; Giuliano M; Zucchetto M
    Br J Ophthalmol; 1990 Feb; 74(2):106-8. PubMed ID: 2310723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oscillatory potential and nyctometry in insulin-dependent diabetics.
    Frost-Larsen K; Larsen HW; Simonsen SE
    Acta Ophthalmol (Copenh); 1980 Dec; 58(6):879-88. PubMed ID: 7036647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular recovery time recorded by nyctometry--a screening method for selection of patients who are at risk of developing proliferative diabetic retinopathy. Results of a 5-year follow-up.
    Frost-Larsen K; Larsen HW
    Acta Ophthalmol Suppl (1985); 1985; 173():39-47. PubMed ID: 3002099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of near normoglycemia for 5 years on progression of early diabetic retinopathy and renal involvement.
    Beck-Nielsen H; Olesen T; Mogensen CE; Richelsen B; Olsen HW; Ehlers N; Charles P; Sørensen NS
    Diabetes Res; 1990 Dec; 15(4):185-90. PubMed ID: 2132407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do oscillatory potentials and macular recovery time reflect metabolic control of diabetes mellitus?
    Midena E; Segato T; Giuliano M
    Ophthalmology; 1989 Aug; 96(8):1274-6. PubMed ID: 2619814
    [No Abstract]   [Full Text] [Related]  

  • 14. The diagnostic value of the oscillatory potentials of the ERG and fluorescein angiography in diabetic proliferative retinopathy.
    Algvere P; Gjötterberg M
    Ophthalmologica; 1974; 168(2):97-108. PubMed ID: 4842096
    [No Abstract]   [Full Text] [Related]  

  • 15. Near-normoglycemia and late diabetic complications. The Oslo Study.
    Dahl-Jørgensen K
    Acta Endocrinol Suppl (Copenh); 1987; 284():1-38. PubMed ID: 3300128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous insulin infusion therapy and retinopathy in patients with type I diabetes.
    Helve E; Laatikainen L; Merenmies L; Koivisto VA
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):313-9. PubMed ID: 3303785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics.
    Lauritzen T; Frost-Larsen K; Larsen HW; Deckert T
    Lancet; 1983 Jan; 1(8318):200-4. PubMed ID: 6130243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular oscillatory potentials in humans. Macular OPs.
    Miyake Y
    Doc Ophthalmol; 1990 Sep; 75(2):111-24. PubMed ID: 2276312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for early impairment of macular function with pattern ERG in type I diabetic patients.
    Caputo S; Di Leo MA; Falsini B; Ghirlanda G; Porciatti V; Minella A; Greco AV
    Diabetes Care; 1990 Apr; 13(4):412-8. PubMed ID: 2318101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline haemoglobin A1c influences retinal function after long-term insulin pump therapy.
    Klefter ON; Holfort SK; Larsen M
    Graefes Arch Clin Exp Ophthalmol; 2016 Mar; 254(3):467-73. PubMed ID: 26108526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.